BizEquity built the category and sells through financial advisors and brokers; EvalyMe sells directly to founders for $14.99/mo. If you already work with an advisor who has BizEquity, use it through them — it may cost you nothing. If you're self-serve and run a software-style business, EvalyMe fits how you think about your numbers.
- Best through an advisor
- BizEquity — advisor-delivered, institutionally familiar, sometimes free via your advisor.
- Best self-serve price
- EvalyMe — free calculator, published $14.99/mo Pro, no quotes or sales calls.
- Best for software businesses
- EvalyMe — MRR, churn, and LTV/CAC as first-class inputs.
- Best for traditional SMBs
- BizEquity — its model and report lineage are built around owner-operated businesses.
The picks at a glance
| Tool | Best for | Price | How you get it |
|---|---|---|---|
| EvalyMe | Founders self-serving a number and a plan | $0 calculator · Pro $14.99/mo | Direct: web calculator and mobile apps, today |
| BizEquity | Owner-operated traditional businesses, advisor relationships | Historically $365/yr; today mostly advisor/broker-delivered (reseller packages ~$1,497 listed) | Usually through your financial advisor or broker |
| Certified appraiser | Disputes, tax, estate, lending | Roughly $2,500–$5,000+ formal | Direct engagement |
What actually differs
BizEquity pioneered online business valuation and reports doing enormous volume — its own materials claim hundreds of thousands of valuations a year, and its patents and advisor partnerships (national broker-dealers among them) are real institutional assets. You don't get that scale by being wrong.
But scale and channel shape the product. BizEquity today is largely something an advisor runs with you, and its direct pricing is no longer a simple published number you can check in ten seconds. EvalyMe is the opposite corner: self-serve, priced on the page, formula published, built around the metrics a software founder already tracks weekly — MRR, churn, growth, LTV/CAC.
The honest framing: BizEquity is an institution you access; EvalyMe is a tool you use. Those suit different people and different businesses.
1.EvalyMe ours
- Best for
- Indie founders, micro-SaaS, recurring-revenue businesses
- Price
- Calculator free · Pro $14.99/mo, published
- Platform
- Web + native iOS and Android apps
- Core output
- Directional range, operating score, exit playbook
Eight inputs, about sixty seconds, no account, and the formula — base multiples, factor adjustments, score weights — is on a public methodology page. Pro adds 30/60/90-day playbooks with task tracking and an AI Advisor for $14.99/mo.
The catch: no advisor network, no institutional history, and no paid relationships that put our report in front of anyone. If your situation needs an institution, we're the wrong tool.
2.BizEquity
- Best for
- Traditional owner-operated businesses, advisor-led planning
- Price
- Not published cleanly; historically $365/yr, now mostly via advisors
- Platform
- Web, often through advisor portals
- Core output
- Patented online valuation report (17-page format historically)
BizEquity's volume claim — hundreds of thousands of valuations a year — is unmatched in this category, and its reports are recognized in advisor and broker channels. If you're doing succession planning with a financial advisor, there's a decent chance they can run one for you as part of the relationship.
The catch: opaque direct pricing, an advisor-shaped process, and a model lineage aimed at traditional small businesses rather than recurring-revenue software. And like every tool on this page, it's still not a certified appraisal when the stakes turn legal.
Our pick, by situation
- You have a financial advisor: ask whether they offer BizEquity valuations. If yes, that's your best free-ish starting point.
- You're a solo founder with a dashboard of metrics: EvalyMe — the inputs, price, and pace match how you already operate.
- You run a restaurant, trade, or local services business: BizEquity's lineage fits your financial shape better than our model does.
- It's for a divorce, estate, or IRS matter: neither — a certified appraiser.
What I'd do today
- Run EvalyMe's free calculator for a private baseline — no signup, no sales follow-up.
- Email your advisor and ask if they can run a BizEquity valuation for you; many can.
- Compare the two numbers. If they're close, trust the shape. If they diverge wildly, figure out which inputs differ before trusting either.
- Work the weakest factor for 30 days, then re-run. Valuation tools are cheapest when used as before/after measurement.
Questions
How much does BizEquity cost? +
We can't tell you with confidence, and that's part of the story. BizEquity has moved from a consumer subscription (reported at $365/year years ago) toward distribution through financial advisors and brokers, where pricing is often bundled or quoted per engagement — reseller packages around $1,497 have been listed. If you have an advisor, ask them; access is sometimes effectively free through the relationship.
Which report is better? +
For a traditional small business — owner-operated, SDE-style financials — BizEquity's report has more institutional history behind it. For a software or recurring-revenue business, EvalyMe's inputs (MRR, churn, LTV/CAC, growth) map to how those businesses are actually bought and sold. Neither replaces a certified appraisal for legal use.
Does BizEquity have an app? +
Not that we're aware of; it's a web service, often accessed through an advisor's portal. EvalyMe ships native iOS and Android apps alongside the web app.
Can my BizEquity report and EvalyMe disagree? +
Yes, and that's expected — different models, different inputs, different data. If two directional estimates disagree wildly, the honest conclusion is that your business's value is uncertain, which is itself useful to know before you negotiate anything.
Why is EvalyMe so much cheaper? +
Different business model. BizEquity sells through advisors who pay for institutional tooling. EvalyMe is self-serve software with a published $14.99/mo Pro plan and a free calculator. We don't have a sales channel to fund.
Competitor details from public sources, checked October 2026. EvalyMe outputs are estimates, not appraisals or investment advice.